No near-term trading implications. The audit re-appointment is procedural and does not affect earnings, cash flow, or business strategy. Monitor the 2028 AGM for approval, but this filing is non-event for stock price.
GSK drugs
GSK drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 17 $51.76entry
- T+1 · 4mo ago −3.32%α −3.16% · $50.04
- T+5 · 4mo ago −1.97%α −1.28% · $50.74
- T+20 · 3mo ago −4.33%α −8.77% · $49.52
- T+60 · 5w ago −9.35%α −14.03% · $46.92
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
GSK announced the re-appointment of Deloitte LLP as its external auditor effective from the financial year ending December 31, 2028, following a competitive tender process led by the Audit & Risk Committee. This is a routine governance matter required by Public Interest Entity rules and carries no material financial or operational implications.
Key Facts
- Board re-appointed Deloitte LLP as external auditor for financial year ending Dec 31, 2028
- Tender process required every 10 years; rotation every 20 years per PIE rules
- Deloitte initially appointed for FY ended Dec 31, 2018
- Re-appointment subject to shareholder approval at 2028 AGM
Financial Impact
No material financial impact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-006706 |
| Document: 0001654954-26-006706-index-headers.html | 0001654954-26-006706 |
| Document: 0001654954-26-006706-index.html | 0001654954-26-006706 |
| Document: 0001654954-26-006706.txt | 0001654954-26-006706 |
Track record
64 reports on GSK
9 of 18 bullish or bearish reports moved the stock their way by T+20. Best: +9.35% at T+60 after the Jul 17, 2026 report. 15 of 21 went positive at some point.
Filters
- Nov 13, 20263d ago 6-K Neutral 4/10 Entry $50.45 Now $50.41 −0.08% settles Dec 14
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $50.64 Now $50.41 −0.45% settles Dec 11
- Nov 6, 202610d ago 6-K Neutral 1/10 Entry $50.33 Now $50.41 +0.16% settles Dec 7
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $49.13 Now $50.41 +2.61% settles Dec 1
- Oct 28, 202619d ago 6-K Neutral 5/10 Entry $48.74 Now $50.41 +3.43% settles Nov 25
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 26, 202621d ago 6-K Neutral 1/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 26, 202621d ago 6-K Neutral 4/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 21, 202626d ago 6-K Bullish 7/10 Entry $50.02 Now $50.41 +0.78% settles Nov 18
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers